See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2022_PROVECTUS_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000315545')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000315545, PROVECTUS BIOPHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,441,957 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 31,836 |
| 3 | remainder_Assets | 39,563 |
| 4 | LiabilitiesCurrent | 7,700,636 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,063,897 |
| 9 | ResearchAndDevelopmentExpense | 2,608,357 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -867,289 |
| 13 | remainder_ComprehensiveNetIncome | -370 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,513,356 |
| 1 | Liabilities | 7,700,636 |
| 2 | Expenses | 4,672,254 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,187,280 |
| 5 | NetIncome | -5,539,543 |
| 6 | ComprehensiveNetIncome | -5,539,728 |
| 7 | BaseVar | 8,376,952 |
| 8 | EconomicCapitalRatio | -2.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
